Skip to content
Rio de Janeiro · São Paulo · Salvador — matters across Brazil
Bruno Marcelos — Escritório de Advocacia

Pauta Regulatória · Daily brief

No. 107

Automatically translated from the Portuguese edition, which prevails in case of discrepancy. Ler em português

Federal Official Gazette

ANS NORMATIVE RESOLUTION No. 666, OF MARCH 13, 2026.

Provides for the technical-care visit to identify serious administrative abnormalities of a care nature in health care plan operators.

Attached is a report with the main changes.

ANS OPERATIONAL RESOLUTION No. 3,108, OF MARCH 13, 2026

Provides for the establishment of the special regime of Technical Direction at UNIMED DO SUDOESTE COOPERATIVA DE TRABALHO MEDICO LTDA.

ANS OPERATIONAL RESOLUTION No. 3,109, OF MARCH 13, 2026

Provides for the establishment of the special regime of Technical Direction at UNIMED-SÃO GONÇALO – NITERÓI SOC.COOP.SERV.MED E HOSP LTDA.

ANS OPERATIONAL RESOLUTION No. 3,110, OF MARCH 13, 2026

Provides for the establishment of the special regime of Technical Direction at UNIMED MONTES CLAROS COOPERATIVA DE TRABALHO MÉDICO LTDA.

ANS news

ANS releases evaluation of operators based on beneficiary complaints

Data for the 4th quarter of 2025 are available in lists and in a new interactive dashboard, reinforcing the sector’s transparency

https://www.gov.br/ans/pt-br/assuntos/noticias/operadoras/ans-divulga-avaliacao-das-operadoras-com-base-em-reclamacoes-dos-beneficiarios

Open public consultations

  • CP 168. Subject: CP opened for the submission of criticism and suggestions regarding the proposed amendment of Normative Resolutions No. 516 and 521, of 2022. Deadline: Feb 23, 2026 to Apr 9, 2026.
  • CP 169. Purpose: to receive contributions related to the proposed updates to the List of Health Procedures and Events (Rol). Deadline: Mar 11, 2026 to Mar 30, 2026.

Scheduled public hearings

  • AP 64. Public Hearing No. 64 aims to gather contributions regarding the unfavorable preliminary recommendation for the technology: (i) UAT 193 – Olaparib as monotherapy – Treatment of adult patients with metastatic castration-resistant prostate cancer and mutations in the BRCA1 and/or BRCA2 genes, whose disease has progressed after prior treatment with a new hormonal agent. Date: March 20, 2026, from 9:30 a.m. to 11 a.m.

Open public calls for input

There is no open public call for input.

Open public calls

No updates.

Other news

– No updates.

Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.